Improved prediction of tacrolimus concentrations early after kidney transplantation using theory‐based pharmacokinetic modelling-Reference-Cited by-同舟云学术

Improved prediction of tacrolimus concentrations early after kidney transplantation using theory‐based pharmacokinetic modelling

Published:2014-08-21 Issue:3 Volume:78 Page:509-523
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Størset Elisabet¹²,Holford Nick³,Hennig Stefanie⁴⁵,Bergmann Troels K.⁴⁶,Bergan Stein⁷⁸,Bremer Sara⁹,Åsberg Anders¹⁸^ORCID,Midtvedt Karsten¹,Staatz Christine E.⁴⁵

Affiliation:

1. Department of Transplant Medicine Oslo University Hospital Rikshospitalet Oslo Norway

2. Institute of Clinical Medicine University of Oslo Oslo Norway

3. Department of Pharmacology and Clinical Pharmacology University of Auckland Auckland New Zealand

4. School of Pharmacy University of Queensland Brisbane Australia

5. Australian Centre of Pharmacometrics Brisbane Australia

6. Department of Clinical Pharmacology Aarhus University Hospital Aarhus Denmark

7. Department of Pharmacology Oslo University Hospital Oslo Norway

8. School of Pharmacy University of Oslo Oslo Norway

9. Department of Medical Biochemistry Oslo University Hospital Oslo Norway

Funder

Shipowner Tom Wilhelmsens Foundation

The Norwegian Pharmaceutical Society

University of Queensland Summer Research Scholarship

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.12361

Reference51 articles.

1. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation;Staatz;Clin Pharmacokinet,2004

2. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference;Wallemacq;Ther Drug Monit,2009

3. Lessons from routine dose adjustment of tacrolimus in renal transplant patients based on global exposure;Saint-Marcoux;Ther Drug Monit,2013

4. Forecasting individual pharmacokinetics;Sheiner;Clin Pharmacol Ther,1979

5. Maximum a posteriori Bayesian estimation of mycophenolic acid area under the concentration-time curve: is this clinically useful for dosage prediction yet?;Staatz;Clin Pharmacokinet,2011

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A joint population pharmacokinetic model to assess the high variability of whole-blood and intracellular tacrolimus in early adult renal transplant recipients;International Immunopharmacology;2024-08

2. Evaluation of Published Population Pharmacokinetic Models to Inform Tacrolimus Therapy in Adult Lung Transplant Recipients;Therapeutic Drug Monitoring;2024-05-09

3. HDL-C and creatinine levels at 1 month are associated with patient 12-month survival rate after kidney transplantation;Pharmacogenetics and Genomics;2023-12-04

4. A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction;Kidney International;2023-10

5. Population Pharmacokinetic Model for Unbound Concentrations of Daptomycin in Patients with MRSA Including Patients Undergoing Hemodialysis;European Journal of Drug Metabolism and Pharmacokinetics;2023-03